Table 1.

Malaria outcomes at 8 weeks by study arm (N = 284)

	Azithromycin (N = 150)	Amoxicillin (N = 133)	Odds Ratio or Mean Difference (95% CI)	P value
Positive RDT for malaria	13 (8.7%)	15 (11.2%)	0.75 (0.34 to 1.63)	0.46
Fever*	7 (4.7%)	5 (3.7%)	1.26 (0.39 to 4.36)	0.70
Positive RDT plus fever*	6 (4.0%)	4 (3.0%)	1.35 (0.38 to 5.40)	0.64
Hemoglobin, g/dL2	9.2 (1.2)	9.3 (1.5)	−0.07 (−0.44 to 0.30)	0.70
Anemia (< 11.0 g/dL)†	94 (92.2%)	81 (86.2%)	1.93 (0.77 to 5.09)	0.17
Received medical care since last study visit‡
Week 1	5 (3.3%)	7 (5.2%)	0.62 (0.18 to 1.98)	0.42
Week 2	6 (3.9%)	7 (5.1%)	0.75 (0.24 to 2.32)	0.62
Week 3	8 (5.5%)	5 (3.7%)	1.50 (0.49 to 5.06)	0.49
Week 4	6 (4.1%)	5 (3.8%)	1.08 (0.32 to 3.83)	0.90
Week 8	9 (6.3%)	9 (7.5%)	0.83 (0.32 to 2.21)	0.71

CI = confidence interval; RDT = rapid diagnostic test.

^*Fever defined as tympanic temperature > 37.5°C.

^†In subset with hemoglobin measurements at 8 weeks (N = 196).

^‡Received care at a primary healthcare facility per caregiver report.